132 related articles for article (PubMed ID: 38623858)
1. Impact Of PET/CT On Treatment In Patients With Head And Neck Squamous Cell Carcinoma.
García-Curdi F; Lois-Ortega Y; Muniesa-Del Campo A; Andrés-Gracia A; Sebastián-Cortés JM; Vallés-Varela H; Lambea-Sorrosal JJ
Otolaryngol Pol; 2024 Apr; 78(2):29-34. PubMed ID: 38623858
[TBL] [Abstract][Full Text] [Related]
2. The Role of FDG Positron Emission Tomography/Contrast--Enhanced Computed Tomography in Preoperative Staging and Postoperative Follow-up in Rectal Cancer Surgery.
Omarov N; Uymaz DS; Kulle CB; Ozkan ZG; Azamat S; Keskin M; Bulut MT
Pol Przegl Chir; 2022 Feb; 94(6):10-16. PubMed ID: 36468505
[TBL] [Abstract][Full Text] [Related]
3. Impact of (18)F-FDG PET/CT staging on management and prognostic stratification in head and neck squamous cell carcinoma: A prospective observational study.
Ryu IS; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Eur J Cancer; 2016 Aug; 63():88-96. PubMed ID: 27288873
[TBL] [Abstract][Full Text] [Related]
4. Correlation between PET/CT and CT in the staging prior to the treatment of head and neck squamous cell carcinoma.
García-Curdi F; Lois-Ortega Y; Muniesa-Del Campo A; McGee-Laso A; Sebastián-Cortés JM; Vallés-Varela H; Lambea-Sorrosal JJ
Braz J Otorhinolaryngol; 2021; 87(1):11-18. PubMed ID: 31337597
[TBL] [Abstract][Full Text] [Related]
5. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R
Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Accuracy of
Murtojärvi S; Malaspina S; Kinnunen I; Tuokkola T; Honka MJ; Saunavaara V; Tolvanen T; Schrey A; Kemppainen J
Contrast Media Mol Imaging; 2022; 2022():8676787. PubMed ID: 36082064
[TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study.
Lonneux M; Hamoir M; Reychler H; Maingon P; Duvillard C; Calais G; Bridji B; Digue L; Toubeau M; Grégoire V
J Clin Oncol; 2010 Mar; 28(7):1190-5. PubMed ID: 20124179
[TBL] [Abstract][Full Text] [Related]
8.
van den Bosch S; Doornaert PAH; Dijkema T; Zwijnenburg EM; Verhoef LCG; Hoeben BAW; Kasperts N; Smid EJ; Terhaard CHJ; Kaanders JHAM
Radiother Oncol; 2020 Jan; 142():107-114. PubMed ID: 31439447
[TBL] [Abstract][Full Text] [Related]
9. Response evaluation of cervical lymph nodes after chemoradiation in patients with head and neck cancer - does additional [18F]FDG-PET-CT help?
Dejaco D; Uprimny C; Widmann G; Riedl D; Moser P; Arnold C; Steinbichler TB; Kofler B; Schartinger VH; Virgolini I; Riechelmann H
Cancer Imaging; 2020 Sep; 20(1):69. PubMed ID: 32993805
[TBL] [Abstract][Full Text] [Related]
10. Use of Diffusion-Weighted Imaging and
Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA
Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of quantitative diffusion-weighted imaging and 18-F-FDG-PET in head and neck squamous cell carcinoma treated by (chemo)radiotherapy.
Martens RM; Noij DP; Koopman T; Zwezerijnen B; Heymans M; de Jong MC; Hoekstra OS; Vergeer MR; de Bree R; Leemans CR; de Graaf P; Boellaard R; Castelijns JA
Eur J Radiol; 2019 Apr; 113():39-50. PubMed ID: 30927958
[TBL] [Abstract][Full Text] [Related]
12. Clinical Practice in PET/CT for the Management of Head and Neck Squamous Cell Cancer.
Goel R; Moore W; Sumer B; Khan S; Sher D; Subramaniam RM
AJR Am J Roentgenol; 2017 Aug; 209(2):289-303. PubMed ID: 28731808
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic performance of
Chaput A; Robin P; Podeur F; Ollivier M; Keromnes N; Tissot V; Nonent M; Salaün PY; Rousset J; Abgral R
Laryngoscope; 2018 Feb; 128(2):378-385. PubMed ID: 28600822
[TBL] [Abstract][Full Text] [Related]
14. Impact of 18F-2-fluoro-2-deoxy-D-glucose PET/computerized tomography on the initial staging and changing the management intent in head and neck squamous cell carcinoma.
Kandeel A; Saied M; Aldaly M; Darwish H; Alsayed Y
Nucl Med Commun; 2021 Feb; 42(2):216-224. PubMed ID: 33165255
[TBL] [Abstract][Full Text] [Related]
15. Influence of FDG-PET on primary nodal target volume definition for head and neck carcinomas.
van Egmond SL; Piscaer V; Janssen LM; Stegeman I; Hobbelink MG; Grolman W; Terhaard CH
Acta Oncol; 2016; 55(9-10):1099-1106. PubMed ID: 27219720
[TBL] [Abstract][Full Text] [Related]
16. Should PET/CT be implemented in the routine imaging work-up of locally advanced head and neck squamous cell carcinoma? A prospective analysis.
Cacicedo J; Fernandez I; Del Hoyo O; Dolado A; Gómez-Suarez J; Hortelano E; Sancho A; Pijoan JI; Alvarez J; Espinosa JM; Gaafar A; Bilbao P
Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1378-89. PubMed ID: 25952280
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of
Ha SC; Roh JL; Kim JS; Lee JH; Choi SH; Nam SY; Kim SY
Acta Otolaryngol; 2019 Sep; 139(9):810-815. PubMed ID: 31274365
[No Abstract] [Full Text] [Related]
18.
Kim SA; Roh JL; Kim JS; Lee JH; Lee SH; Choi SH; Nam SY; Kim SY
Eur J Cancer; 2017 Feb; 72():62-70. PubMed ID: 28027517
[TBL] [Abstract][Full Text] [Related]
19. Correlations between DW-MRI and
Connor S; Sit C; Anjari M; Szyszko T; Dunn J; Pai I; Cook G; Goh V
Cancer Rep (Hoboken); 2021 Aug; 4(4):e1360. PubMed ID: 33960739
[TBL] [Abstract][Full Text] [Related]
20. Positron Emission Tomography-Computed Tomography Surveillance after (Chemo)Radiotherapy in Advanced Head and Neck Squamous Cell Cancer: Beyond the PET-NECK Protocol.
Zhou S; Rulach R; Hendry F; Stobo D; James A; Dempsey MF; Grose D; Lamb C; Schipani S; Rizwanullah M; Wilson C; Lau YC; Paterson C
Clin Oncol (R Coll Radiol); 2020 Oct; 32(10):665-673. PubMed ID: 32561027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]